The Brugada syndrome is characterized by ST-segment elevation in leads V 1 to V 3 with a right bundle branch block pattern and nocturnal sudden cardiac death due to ventricular fibrillation (1) (2) (3) (4) (5) .
Arrhythmias such as premature ventricular contraction, monomorphic ventricular tachycardia, polymorphic ventricular tachycardia (6 -8) , and ventricular fibrillation have been reported. In addition, atrial arrhythmia has also been reported in patients with Brugada syndrome (2,9 -13). Recently, it has been reported that mutations of the sodium channel gene cause Brugada syndrome (4 -19) . If Brugada syndrome is a sodium channel disease, it is possible that an electrical abnormality of the myocardium might exist not only in the ventricular myocardium (5, 20) but also in the atrial myocardium. Thus, in this study, we evaluated atrial vulnerability in patients with Brugada syndrome.
METHODS

Patients.
The patient group consisted of 18 patients with Brugada syndrome (Table 1) . The patients were all men, ranging in age from 33 to 71 years (mean 49 Ϯ 11). All of the patients with Brugada syndrome showed the typical electrocardiographic (ECG) "Brugada sign," which was defined previously (4) . Ten patients with Brugada syndrome had experienced syncopal episodes or had a family history of sudden cardiac death. The other eight patients were asymptomatic and had no family history of sudden cardiac death. The control group consisted of 12 age-and gender-matched subjects (mean age 48 Ϯ 10 years [range 35 to 60]) who had no sign of the Brugada-type ECG change and no episodes of atrial fibrillation (AF), nor could AF be induced by programmed electrical stimulation. The 12 subjects in the control group included 9 patients with paroxysmal supraventricular tachycardia without manifest Wolf-Parkinson-White syndrome and 3 patients with idiopathic ventricular tachycardia. Study protocol. EVALUATION OF INCIDENCE OF AF. The occurrence of AF was evaluated by clinical follow-up (every month), observing the patient's symptoms, and 24-h Holter ambulatory ECG recording. Continuous ECG monitoring was performed from two to three weeks during administration.
ELECTROPHYSIOLOGIC STUDY. After obtaining the patients' written, informed consent, an electrophysiologic study was performed in all 12 control subjects and in 14 of 18 patients with Brugada syndrome. After right femoral and right carotid venous access was obtained, three quadripolar electrode catheters (6F) with an interelectrode distance of 5 mm (EP Technologies, Boston Scientific, Inc., Sunnyvale, California) were positioned in the right atrial appendage (RAA), His bundle region, and right ventricle, and an octopolar catheter (6F) with an interelectrode distance of 2.5 mm (EP Technologies, Boston Scientific, Inc.) was positioned into the coronary sinus (CS). Endocardial potentials were recorded by bipolar and filtered to record frequencies of 30 to 400 Hz. Programmed electrical stimulation was performed at an intensity of twice the threshold and for 2 ms in duration through the distal electrodes in the RAA, using the SEC3105 Nihon-Koden pulse generator. A premature stimulus (S 2 ) was delivered after eight beats of drive pacing (S 1 ) at a basic cycle length of 600 ms. The S 1 -S 2 interval was decreased in 10-ms steps until the effective refractory period (ERP) of the RAA was reached. The first deflection in amplified recordings of the atrial electrograms was taken as the onset of atrial depolarization.
Atrial vulnerability was evaluated by the ERP of the RAA, intra-atrial conduction time (CT) and conduction delay (CD) during the basic cycle length of S 1 and extrastimulus of S 2 , duration of the local right atrial potential during the basal cycle length of S 1 and extrastimulus of S 2 , and repetitive atrial firing (RAF) and induced AF in response to S 2 .
The occurrence of premature atrial contraction (PAC) and AF was evaluated at baseline and after infusion of 2 g isoproterenol in all control subjects and patients with Brugada syndrome in whom an electrophysiologic study had been performed.
DEFINITIONS.
The ERP was defined as the longest coupling interval (S 1 -S 2 ) at which the stimulus failed to propagate a response. The intra-atrial CT was defined as the interval from the stimulus to the atrial deflection at the distal portion of the CS. The CD was defined as the difference between the CT at S 2 and that at S 1 , and a positive CD was defined as an increase of Ն20 ms in CT at S 2 compared with that at S 1 . The CD zone was defined as the range of the coupling interval that shows a positive CD (21) (22) (23) .
Abbreviations and Acronyms
AF ϭ atrial fibrillation CD ϭ conduction delay CS ϭ coronary sinus CT ϭ conduction time ERP ϭ effective refractory period FAA ϭ fragmented atrial activity PAC ϭ premature atrial contraction RA ϭ right atrium/atrial RAA ϭ right atrial appendage RAF ϭ repetitive atrial firing The presence of fragmented atrial activity (FAA) was defined as the duration of A2 at the ERP of RAA/duration of A1 Ն150%. The FAA zone was defined as the range of the coupling interval that resulted in FAA (24 -26) . Repetitive atrial firing was defined as the occurrence of two or more premature atrial complexes (21, 22) .
Induced AF was defined as AF that was induced by programmed electrical stimulation and persisted for Ͼ30 s. Spontaneous AF was defined as AF detected by 12-lead electrocardiography or ambulatory ECG monitoring without any maneuvers, including programmed electrical stimulation and drug stress tests. Statistical analysis. Quantitative data are expressed as the mean value Ϯ SD. The statistical significance of the differences was analyzed by using the Student t test for unpaired values. A value of p Ͻ 0.05 was considered as statistically significant.
RESULTS
Clinical characteristics and incidence and frequency of AF in patients with Brugada syndrome. Spontaneous paroxysmal AF was detected in 7 (39%) of 18 patients with Brugada syndrome: 5 with ventricular fibrillation or a positive family history of sudden death and 2 asymptomatic patients with Brugada syndrome and no family history of sudden death. All patients had a paroxysmal attack of AF, and none of the patients showed persistent or chronic AF.
The frequency of AF attack was low in the majority of patients with Brugada syndrome (Table 1 ). The patients' mean age of AF onset was 56 Ϯ 11 years.
The Holter ambulatory ECG showed that PAC rarely occurred in patients with Brugada syndrome; mean, median, and range of PACs were 5 Ϯ 6, 12, and 0 to 23/day, respectively. Initiation of AF was detected in Patient 18 only; AF was followed by rapid firing of PAC, but no PACs were observed before the occurrence of AF (Fig. 1) . Isoproterenol infusion. Isoproterenol infusion did not induce any PACs or AF in the control subjects. Isoproterenol infusion induced PAC and AF in only one patient with Brugada syndrome (Patient 18), but neither PAC nor AF occurred in any of the other patients. Atrioventricular conduction. The ventricular response during spontaneous AF in patients with Brugada syndrome was relatively slow (Fig. 2) ; the mean heart rate during AF was 63 Ϯ 10 beats/min.
The AH interval was significantly prolonged (p Ͻ 0.001) in the Brugada syndrome group (96.9 Ϯ 10.6 ms), as compared with that in the control group (73.8 Ϯ 15.3 ms). The HV interval was prolonged in the Brugada syndrome group, but not significantly so (41.3 Ϯ 6.7 vs. 36.2 Ϯ 6.5 ms in control group, p ϭ 0.057). The ERP of atrioventricular node was prolonged in patients with Brugada syndrome (350.7 Ϯ 69.9 vs. 271.8 Ϯ 42.0 ms in control group, p Ͻ 0.001) (Fig. 2) . The one-to-one conduction of the (Fig. 3) . There was no significant difference between the CT at S 1 (CT1) in patients with Brugada syndrome and that in the control group (119.4 Ϯ 15.7 vs. 110.1 Ϯ 19.1 ms), but the CT at S 2 (CT2) in the Brugada syndrome group was markedly delayed (168.4 Ϯ 17.5 vs. 131.8 Ϯ 13.0 ms in control group, p Ͻ 0.001) (Fig. 4) .
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All of the patients with Brugada syndrome had a positive CD (49.0 Ϯ 13.7 vs. 21.8 Ϯ 12.2 ms in control group, p Ͻ 0.001) (Fig. 3) . The CD zone was markedly wider in the Brugada syndrome group than in the control group (37.1 Ϯ 14.4 vs. 20.0 Ϯ 11.0 ms, p Ͻ 0.05).
There was no significant difference between the duration of A1 in patients with Brugada syndrome and that in the control group (51.3 Ϯ 6.0 vs. 49.9 Ϯ 5.3 ms in control group), but the A2 in the Brugada syndrome group was markedly prolonged compared with that in control group (80.3 Ϯ 18.0 vs. 59.3 Ϯ 9.2 ms, p Ͻ 0.01) (Fig. 5) . The prolongation of A2 compared with A1 was more prominent in the Brugada syndrome group than in the control group (156.5 Ϯ 27.8% vs. 118.8 Ϯ 12.5%, p Ͻ 0.001) (Fig. 4) . Half of the patients with Brugada syndrome showed positive FAA, but only one patient in the control group showed positive FAA. The FAA zone was wider in Brugada syndrome (43.0 Ϯ 25.8 ms). Brugada syndrome patients without a spontaneous AF attack. Atrial vulnerability in the 11 Brugada syndrome patients who had no spontaneous AF attack was evaluated. There was no difference between the ERP of RA in the Brugada syndrome group without AF and that in the control group (243.6 Ϯ 28.7 vs. 243.3 Ϯ 20.6 ms). The indexes of atrial conduction (CT2, CD, and CD zone) were 
DISCUSSION
Polymorphic ventricular tachycardia and ventricular fibrillation in patients with Brugada syndrome may be lethal, and the implantable cardioverter-defibrillator is necessary for the treatment of Brugada syndrome (1,2). Recently, it has been Morita et al. October 16, 2002 October 16, :1437 AF in Brugada Syndrome
shown that mutations in the cardiac sodium channel gene, which result in slow recovery from inactive states of the sodium channel or sodium channel dysfunction, cause Brugada syndrome (14 -18) . This functional change in the mutational sodium channel will explain the conduction abnormality of the ventricle and the easy inducibility of ventricular fibrillation (19) , the late activation in the right ventricular outflow tract, and the abnormal late potential (20) . If a mutation in the cardiac sodium channel does in fact cause Brugada syndrome (14 -16,19) , a myocardial electrical abnormality might exist not only in the ventricular myocyte but also in the atrial myocyte. We therefore evaluated the incidence of AF and electrical abnormality in the atrium in Brugada syndrome. In this study, we found that atrial vulnerability was enhanced, and the incidence of AF was increased in patients with Brugada syndrome. Incidence of AF in Brugada syndrome. Some reports demonstrated the ECGs of AF in patients with Brugada syndrome (1-4,10 -13), but the exact incidence of AF in patients with Brugada syndrome is not known. Anzelevitch et al. (2) reported that only 10% of patients with Brugada syndrome exhibit paroxysmal AF. In the present study, the incidence of spontaneous AF in patients with Brugada syndrome was high (39%), and the incidence of AF induced by electrical stimulation was also high. These results show that AF is not rare in patients with Brugada syndrome. Spontaneous PACs on the Holter ambulatory ECG recording were rare in our Brugada syndrome group. Isoproterenol infusion induced AF in only one patient, but PAC and AF were not induced by isoproterenol infusion in the other patients. Therefore, we were not able to evaluate the trigger of AF and its foci (28, 29) . Our study indicates that the incidence of AF in patients with Brugada syndrome was high, but the frequency of AF attack in each patient was low. This suggests that the substrate of AF (that is, abnormal atrial vulnerability) exists and results in random reentry in the atrium, but the trigger of AF (i.e., PAC) is rare in patients with Brugada syndrome. Characteristics of AF and atrioventricular conduction in Brugada syndrome. Because the ventricular response during paroxysmal AF was not rapid in patients with Brugada syndrome, it was thought that the atrioventricular conduction was decreased. Furthermore, ECG recordings of AF in some reports have shown a slow ventricular response during AF, and the HV interval was also prolonged in patients with Brugada syndrome (1, 3, 11, 12) . In the present study, the patients with Brugada syndrome showed slower one-to-one atrioventricular conduction, as measured by atrial pacing, as compared with the control group, and the AH and HV intervals and ERP of the atrioventricular node were prolonged in patients with Brugada syndrome. Slow atrioventricular conduction results in a slow ventricular response during AF. Because it is believed that vagal activity plays an important role in ST-segment elevation and the occurrence of ventricular fibrillation in patients with Brugada syndrome (5), the vagal activity might be related to the initiation of paroxysmal AF and slower atrioventricular conduction in patients with Brugada syndrome. It has been reported that cardiac sodium channel mutations caused the long QT syndrome, Brugada syndrome, and cardiac conduction disease. Because the sodium channel mutation reported in Brugada syndrome showed sodium channel dysfunction, such an abnormal sodium channel would cause an atrioventricular conduction disturbance (27) . 
